课题基金 / 基金详情

Analysis of HNF-related genes responsible for the development of type 2 diabetes in Japanese

Analysis of HNF-related genes responsible for the development of type 2 diabetes in Japanese
日本人患 2 型糖尿病的 HNF 相关基因分析
批准号:
11470229
负责人:
TAKEDA Jun
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

TAKEDA Jun的其他基金

相似基金

相关文献

中文摘要
翻译
编码HNF转录因子的基因突变与MODY有关,MODY是一种早发性糖尿病的单基因形式。孤儿受体SHP调节HNF-4α (MODY1)转录活性的能力表明SHP是MODY的候选基因。我们筛选了173名无亲缘关系的日本早发性糖尿病患者进行该基因突变,并在6名受试者中发现了5种不同的突变,均以杂合状态存在。有趣的是,所有突变的受试者在糖尿病发病时都是轻度或中度肥胖,对这些个体的谱系分析表明,SHP突变与肥胖有关,而不是与MODY有关。突变蛋白的功能研究表明,突变导致SHP活性的丧失。这些结果表明,SHP基因的遗传变异有助于体重增加。为了阐明SHP突变与其他致糖尿病因素之间可能的相互作用,我们对更多具有SHP突变的c先显子进行了MODY基因突变的重新筛选,并在一名受试者中发现了一个MODY3突变。虽然MODY3的主要特征是β细胞功能障碍,但在该受试者中观察到肥胖和胰岛素抵抗,这表明SHP突变改变了表型。由于日本的2型糖尿病也主要是由于β细胞功能障碍,SHP突变可能影响高危人群的易感性。据此,对日本成人2型糖尿病患者中SHP突变的患病率进行了评估。对274名糖尿病患者和305名非糖尿病患者的基因进行了直接测序。在糖尿病组和对照组中,分别有9名(3.3%)和1名(0.3%)受试者发现活性降低的突变。两组之间的频率差异具有统计学意义(p=0.0088),表明与轻度肥胖相关的SHP突变增加了日本人晚年对2型糖尿病的易感性。少
英文摘要
Mutations in genes encoding HNF transcription factors are associated with MODY, a monogenic form of early-onset diabetes mellitus. The ability of the orphan receptor SHP to modulate the transcriptional activity of HNF-4α (MODY1), suggested SHP as a candidate MODY gene. We screened 173 unrelated Japanese subjects with early-onset diabetes for mutations in this gene and found five different mutations in six subjects, all present in the heterozygous state. Interestingly, all of the subjects with the mutations were mildly or moderately obese at onset of diabetes, and analysis of the lineages of these individuals indicated that the SHP mutations were associated with obesity rather than with MODY. Functional studies of the mutant proteins show that the mutations result in the loss of SHP activity. These results suggest that genetic variation in the SHP gene contributes to increased body weight.To clarify the possible interplay between the SHP mutations and other diabetogenic factors, diabeti … More c probands with the SHP mutations were re-screened for mutations in the MODY genes, and one MODY3 mutation was identified in one subject. Although MODY3 is characterized primarily by β-cell dysfunction, obesity and insulin resistance were observed in this subject, suggesting that the SHP mutation modifies the phenotype. As type 2 diabetes in Japanese also is due primarily to β-cell dysfunction, SHP mutations might influence susceptibility in people at risk. Accordingly, the prevalence of SHP mutations in adult-onset type 2 diabetes in Japanese was evaluated. Direct sequencing of the gene in 274 diabetic and 305 non-diabetic subjects was performed. Mutations with reduced activity were found in nine (3.3 %) and one (0.3 %) subjects in the diabetic and control groups, respectively. The frequency difference between the two groups was statistically significant (p=0.0088), suggesting that SHP mutations associated with mild obesity increase susceptibility to type 2 diabetes in later life in Japanese. Less
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
H. Mori et al.: "The Pro^<12>-Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population : Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes"Diabetes. 50. 891-894
H. Mori等人:“PPAR-γ中的Pro^ 12 -Ala取代与一般人群对糖尿病发展的抵抗力相关:可能参与2型糖尿病个体的胰岛素分泌受损”糖尿病。 50.891-894
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Sanyal, et al.: "Differential regulation of the orphan nuclear receptor SHP gene promoter by orphan nuclear receptor ERR isoforms"J.Biol.Chem.. 277. 1739-1748 (2002)
S.Sanyal 等人:“孤儿核受体 ERR 亚型对孤儿核受体 SHP 基因启动子的差异调节”J.Biol.Chem.. 277. 1739-1748 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Aihara et al.: "Assignment of SLC17A6 (alias DNPI), the gene encoding brain/pancreatic islet-type Na^+- dependent inorganic phosphate cotransporter to human chromosome 11p14.3"Cytogenet.Cell Genet.. 92. 167-169 (2001)
Y.Aihara 等人:“将 SLC17A6(别名 DNPI)(编码脑/胰岛型 Na^2 依赖的无机磷酸盐共转运蛋白的基因)分配给人类染色体 11p14.3”Cytogenet.Cell Genet.. 92. 167-169
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Hayashi et al.: "Differentiation-associated Na^+-dependent inorganic phosphate cotransporter (DNPI) is a vesicular glutamate transporter in endocrine glutamatergic systems"J.Biol.Chem.. 276. 43400-43406 (2001)
M.Hayashi等人:“分化相关的Na+依赖性无机磷酸协同转运蛋白(DNPI)是内分泌谷氨酸系统中的囊泡谷氨酸转运蛋白”J.Biol.Chem..276.43400-43406(2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Research on archive sharing of English video teaching materials for flipped classrooms utilizing the scale of national colletes of technology
    • 批准号:
      18K00816
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.75万
    • 财政年份:
      2018
    • 负责人:
      TAKEDA Jun
    • 依托单位:
    Missing link between marine protected area and drug trafficking - Toward the study of "protected area for the crime deterrence".
    Broadband single-shot spectroscopy: visualization of nonlinear optical responses under extremely driving fields
    • 批准号:
      16H04001
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2016
    • 负责人:
      TAKEDA Jun
    • 依托单位:
    Electron-Phohon Coupling Dynamics in Monolayers via Surface-Enhanced Raman Scattering
    • 批准号:
      26610083
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2014
    • 负责人:
      TAKEDA Jun
    • 依托单位:
    国内基金
    海外基金
    MODY-X 家系 SLC19A2 基因突变诱发高血糖表型的致病机理研究
    • 批准号:
      24ZR1456800
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      刘丽梅
    • 依托单位:
    HNF1a-Q125ter 诱发 MODY3 患者磺酰脲类药 物失效的作用及机制研究
    • 批准号:
      Q24H070009
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      陈银玲
    • 依托单位:
    MODY家系中APPL1基因突变诱发糖尿病的致病机理研究
    • 批准号:
      82400974
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2024
    • 负责人:
      张娟
    • 依托单位:
    鞘氨醇介导磺脲类药物治疗MODY3的机制研究
    • 批准号:
      82300913
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      付俊玲
    • 依托单位: